华大基因：二级市场股价受资本市场环境等诸多因素的影响

Core Viewpoint - BGI Genomics stated on October 22 that its stock price in the secondary market is influenced by various factors including the capital market environment, macroeconomic conditions, and investor expectations [1] Group 1 - The company aims to continuously improve operational efficiency and management levels [1] - BGI Genomics is committed to solid business operations to enhance company performance [1] - The company strives to provide returns to its investors [1]